Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Idea to Innovation

McGill University

$9,000.00

Market Assessment application: market assessment of a rapid, reagent-free technology for identification of antibiotic-resistant bacteria by ATR-FTIR spectroscvopy

FY 2015-16

Summary
The objective of this NSERC-I2I market assessment application is to investigate the market potential of MIR Direct, a new and rapid technology developed at McGill University for bacteria identification in hospital clinical microbiology laboratories. MIR Direct employs ""whole-organism fingerprinting"" by attenuated total reflectance-Fourier transform infrared (ATR-FTIR) spectroscopy to identify bacterial species. Furthermore, this technology has the capability to discriminate between antibiotic-resistant and antibiotic-susceptible strains of the same bacterial species, which is critically important for the timely diagnosis of infections caused by antibiotic-resistant bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE), and the appropriate use of antibiotics. Advantages of the MIR Direct technology include: (i) minimal sample preparation, (ii) reagent-free analysis, (iii) simple (one-step), universally applicable analysis protocol, (iv) fast turnaround time (1-2 min),and (v) low cost per test. Accordingly, a market assessment study will be undertaken to guide the McGill technology transfer office in determining the commercialization strategy for this promising new bacteria identification technology.
Program
Idea to Innovation
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
491321-2015
Name nom
Ismail, Ashraf
Department département
Food Science and Agricultural Chemistry
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
9000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
3403
Research subject group en
Physical chemistry
Research subject group fr
Chimie physique
Research subject en
Spectroscopy
Research subject fr
Spectroscopie
Partie
1
Nb partie
1
Application title
Market Assessment application: market assessment of a rapid, reagent-free technology for identification of antibiotic-resistant bacteria by ATR-FTIR spectroscvopy
Keyword
NSERC
Application summary
The objective of this NSERC-I2I market assessment application is to investigate the market potential of MIR Direct, a new and rapid technology developed at McGill University for bacteria identification in hospital clinical microbiology laboratories. MIR Direct employs ""whole-organism fingerprinting"" by attenuated total reflectance-Fourier transform infrared (ATR-FTIR) spectroscopy to identify bacterial species. Furthermore, this technology has the capability to discriminate between antibiotic-resistant and antibiotic-susceptible strains of the same bacterial species, which is critically important for the timely diagnosis of infections caused by antibiotic-resistant bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE), and the appropriate use of antibiotics. Advantages of the MIR Direct technology include: (i) minimal sample preparation, (ii) reagent-free analysis, (iii) simple (one-step), universally applicable analysis protocol, (iv) fast turnaround time (1-2 min),and (v) low cost per test. Accordingly, a market assessment study will be undertaken to guide the McGill technology transfer office in determining the commercialization strategy for this promising new bacteria identification technology.